ATE425763T1 - Verwendung von zusammensetzungen mit der biologischen aktivitat der vasoaktiven intestinalen peptide zur behandlung von sarcoidose - Google Patents

Verwendung von zusammensetzungen mit der biologischen aktivitat der vasoaktiven intestinalen peptide zur behandlung von sarcoidose

Info

Publication number
ATE425763T1
ATE425763T1 AT03722171T AT03722171T ATE425763T1 AT E425763 T1 ATE425763 T1 AT E425763T1 AT 03722171 T AT03722171 T AT 03722171T AT 03722171 T AT03722171 T AT 03722171T AT E425763 T1 ATE425763 T1 AT E425763T1
Authority
AT
Austria
Prior art keywords
treatment
sarcoidosis
peptides
vasoactive intestinal
compositions
Prior art date
Application number
AT03722171T
Other languages
English (en)
Inventor
Dorian Bevec
Original Assignee
Mondobiotech Licensing Out Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mondobiotech Licensing Out Ag filed Critical Mondobiotech Licensing Out Ag
Application granted granted Critical
Publication of ATE425763T1 publication Critical patent/ATE425763T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT03722171T 2002-06-10 2003-06-05 Verwendung von zusammensetzungen mit der biologischen aktivitat der vasoaktiven intestinalen peptide zur behandlung von sarcoidose ATE425763T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02012767 2002-06-10

Publications (1)

Publication Number Publication Date
ATE425763T1 true ATE425763T1 (de) 2009-04-15

Family

ID=29724383

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03722171T ATE425763T1 (de) 2002-06-10 2003-06-05 Verwendung von zusammensetzungen mit der biologischen aktivitat der vasoaktiven intestinalen peptide zur behandlung von sarcoidose

Country Status (13)

Country Link
US (2) US20060241028A1 (de)
EP (1) EP1515745B1 (de)
JP (1) JP2005535607A (de)
CN (2) CN1313149C (de)
AT (1) ATE425763T1 (de)
AU (1) AU2003236072B2 (de)
BR (1) BR0305039A (de)
CA (1) CA2488358A1 (de)
DE (1) DE60326723D1 (de)
DK (1) DK1515745T3 (de)
HK (1) HK1080363B (de)
NO (1) NO330954B1 (de)
WO (1) WO2003103702A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2327640T3 (es) 2003-07-14 2009-11-02 Mondobiotech Ag Sustancias biologicamente activas a partir de un peptido intestinal vasoactivo para el tratamiento de afecciones pulmonares intersticiales.
US7595294B2 (en) * 2004-10-08 2009-09-29 Transition Therapeutics, Inc. Vasoactive intestinal polypeptide pharmaceuticals
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
WO2007073486A2 (en) 2005-12-20 2007-06-28 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
EP4074327A1 (de) 2008-06-27 2022-10-19 Duke University Therapeutika mit elastinähnlichen peptiden
CN101434649B (zh) * 2008-12-12 2012-04-25 余榕捷 一种环七肽及其制备方法和应用
DK3311828T3 (da) 2009-08-14 2021-06-28 Phasebio Pharmaceuticals Inc Modificerede vasoaktive tarmpeptider
ES2669190T3 (es) 2011-06-06 2018-05-24 Phasebio Pharmaceuticals, Inc. Uso de péptidos intestinales vasoactivos modificados en el tratamiento de la hipertensión
AU2015255752B2 (en) 2014-05-08 2020-07-23 Immunoforge Co., Ltd. Methods and compositions for treating Cystic Fibrosis
CN114652817A (zh) 2015-02-09 2022-06-24 费斯生物制药公司 用于治疗肌肉疾病和病症的方法和组合物
EP3583933A1 (de) 2018-06-20 2019-12-25 Albert-Ludwigs-Universität Freiburg Verabreichung von aviptadil durch inhalation zur behandlung von chronischer berylliumkrankheit
SG11202111925RA (en) 2019-05-07 2021-11-29 Advita Lifescience Gmbh Vasoactive intestinal peptide (vip) for use in the treatment of drug-induced pneumonitis
EP4232073B1 (de) 2020-12-04 2024-05-01 Centurion Ilac Sanayi Ve Ticaret Anonim Sirketi Neues dosierschema für inhaliertes vasoaktives intestinales polypeptid
WO2022224172A1 (en) * 2021-04-20 2022-10-27 Advita Lifescience Ag Use of aviptadil alone or in combination with alpha lipoic acid as a therapeutic medicament for post-viral infection syndrome

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3898329A (en) * 1971-09-17 1975-08-05 Sami I Said Vasoactive intestinal peptide, composition and method
US3880826A (en) * 1971-09-17 1975-04-29 Sami I Said Vasoactive intestinal peptide
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4237046A (en) * 1979-04-27 1980-12-02 Miklos Bodanszky Polypeptides and methods of preparation
GB8427651D0 (en) 1984-11-01 1984-12-05 Beecham Group Plc Compounds
US4745100A (en) 1985-05-14 1988-05-17 Eye Research Institute Of Retina Foundation Stimulation of tear secretion
GB8525852D0 (en) 1985-10-19 1985-11-20 Beecham Group Plc Compounds
GB8729802D0 (en) 1987-12-22 1988-02-03 Beecham Group Plc Novel compounds
SE8705139D0 (sv) 1987-12-23 1987-12-23 Trion Forskning & Utveckling Forfarande for framstellning av ett stort antal peptidanaloger och nya peptidanaloger
ATE135370T1 (de) 1988-12-22 1996-03-15 Kirin Amgen Inc Chemisch modifizierte granulocytenkolonie erregender faktor
US5141924A (en) 1989-06-30 1992-08-25 Hoffmann-La Roche, Inc. Synthetic vasoactive intestinal peptide analogs
JPH04193896A (ja) 1989-10-26 1992-07-13 Meiji Seika Kaisha Ltd 活性ペプチド
ATE101619T1 (de) 1990-06-26 1994-03-15 Sanwa Kagaku Kenkyusho Co Vip-analogen und ihre verwendung.
AU656230B2 (en) 1991-10-11 1995-01-27 F. Hoffmann-La Roche Ag Cyclic vasoactive peptides
JPH06220090A (ja) 1993-01-22 1994-08-09 Sanwa Kagaku Kenkyusho Co Ltd ポリペプチド
IL105061A (en) * 1993-03-16 2000-11-21 Yeda Res & Dev Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof
JPH07173197A (ja) 1993-12-20 1995-07-11 Sanwa Kagaku Kenkyusho Co Ltd ポリペプチド修飾化合物及びその用途
CA2187322A1 (en) 1994-04-07 1995-10-19 Israel Rubinstein Vasoactive intestinal polypeptide
EP0879246B1 (de) 1996-02-09 2006-05-31 F. Hoffmann-La Roche Ag Herstellung eines vip-analogen
EP0914094A4 (de) 1996-03-28 2000-03-01 Univ Illinois Materialen und verfahren zur herstellung verbesserter liposomaler mittel
EP0985671B1 (de) * 1996-05-31 2003-04-02 Mochida Pharmaceutical Co., Ltd. PYRIDOCARBAZOL DERIVATE DIE EINEN cGMP-PDE INHIBILIERENDEN EFFEKT HABEN
US6217886B1 (en) * 1997-07-14 2001-04-17 The Board Of Trustees Of The University Of Illinois Materials and methods for making improved micelle compositions
DE69941708D1 (de) * 1998-07-20 2010-01-07 Ipsen Pharma Pacap-peptidanaloga
AU7352200A (en) * 1999-09-01 2001-03-26 Regents Of The University Of California, The Novel natriuretic peptide receptors, interacting compounds and methods of regulating proliferation and/or survival of neurons
EP1233811A2 (de) * 1999-11-12 2002-08-28 Leo Rubin Verfahren zur behandlung von herzstillstand oder pulmonarer hypertension und substanzen zur verwendung dafür mit vasoaktivem intestinalen polypeptid und kardiales gerät zur elektrischen und chemischen regulation sowie verwendungsverfahren dafür
CN1487952A (zh) * 2000-11-28 2004-04-07 �ɶ����＼��ʵ���� 具有血管活性肠肽的生物学活性的用于治疗肺动脉和小动脉高压的化合物

Also Published As

Publication number Publication date
EP1515745A1 (de) 2005-03-23
JP2005535607A (ja) 2005-11-24
BR0305039A (pt) 2004-11-09
EP1515745B1 (de) 2009-03-18
HK1080363A1 (en) 2006-04-28
CN101015679A (zh) 2007-08-15
AU2003236072B2 (en) 2008-10-23
NO330954B1 (no) 2011-08-22
DE60326723D1 (de) 2009-04-30
US7951778B2 (en) 2011-05-31
US20060241028A1 (en) 2006-10-26
AU2003236072A1 (en) 2003-12-22
CA2488358A1 (en) 2003-12-18
DK1515745T3 (da) 2009-07-13
CN1313149C (zh) 2007-05-02
WO2003103702A1 (en) 2003-12-18
NO20040488L (no) 2004-04-07
CN1658896A (zh) 2005-08-24
US20080274961A1 (en) 2008-11-06
HK1080363B (zh) 2007-12-21

Similar Documents

Publication Publication Date Title
HK1080363B (zh) 具有血管活性腸肽的生物學活性的化合物在治療結節病中的用途
WO2002043746A3 (en) Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
HUP0004560A2 (hu) Törést gyógyító PTHrP analógok
US9060991B2 (en) Use of GLP-1 analogues for the treatment of disorders associated with dysfunctional synaptic transmission
AU2019275610A1 (en) Improved peptide pharmaceuticals
CN1137898C (zh) 甲状旁腺素的类似物
JP5670190B2 (ja) 機能障害性シナプス伝達に伴う障害の治療用ｇｉｐの使用
SK82096A3 (en) Compounds influencing growth hormone releasing
DE602005026014D1 (de) Proteinartige verbindungen und anwendungen davon
CZ20021026A3 (cs) Analogy parathormonu pro léčbu osteoporózy
JPH10512280A (ja) ＰＴＨおよびＰＴＨｒＰの環式同族体
JP2006506942A5 (de)
JP2024054222A (ja) 活性薬剤の経口投与のための製剤
JPH06228199A (ja) 血液脳関門通過可能なペプチド結合体
JPH08501055A (ja) 神経ペプチドチロシンの生物学的機能を抑制する新規な分子
PT981362E (pt) Metodos de melhoramento do funcionamento do tracto gastrointestinal superior
ES2327640T3 (es) Sustancias biologicamente activas a partir de un peptido intestinal vasoactivo para el tratamiento de afecciones pulmonares intersticiales.
JP2012500284A (ja) ペプチド性ｐｔｈ受容体アゴニスト
ES2291372T3 (es) Agonistas y antagonistas de urotensina-ii.
MX2022008748A (es) Administración oral de péptidos.
ATE234624T1 (de) Zusammensetzungen zur verstärkung der pharmakologischen aktivität von immunosuppressiva
TW201000117A (en) Preparation of a pharmaceutical composition for increasing bone mineral density
Tatemoto et al. and Peptide YY
TH50339B (th) การสมานรอยหักของกระดูกโดยใช้อานาลอกของ PTHrP

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1515745

Country of ref document: EP

EEIH Change in the person of patent owner